Ferrante Karen Jean bought COGT
April 1, 2026 · Form 4 insider transaction
Ferrante Karen Jean bought 686 shares of Cogent Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
686
Price
$0.00
Total value
N/A
InsiderFerrante Karen Jean
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after686
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.